# A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

> **NCT06595238** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 262 (actual)

## Conditions studied

- Obesity or Overweight

## Interventions

- **DRUG:** AZD6234
- **DRUG:** Placebo comparator

## Key facts

- **NCT ID:** NCT06595238
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-01
- **Primary completion:** 2025-08-08
- **Final completion:** 2025-12-03
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06595238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06595238, "A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06595238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*